期刊文献+

自身免疫性肝病及其自身抗体谱分析 被引量:8

Autoimmune liver diseases and their autoantibodies spectral analysis
下载PDF
导出
摘要 目的探讨重庆地区不同类型自身免疫性肝病患者血清中自身抗体谱的特征及其临床应用价值。方法 743例肝病送检样本中81例确诊为自身免疫性肝病,将其分为3组:(1)自身免疫性肝炎(AIH)38例;(2)原发性胆汁性肝硬化(PBC)30例;(3)重叠综合征13例。用间接免疫荧光法检测抗核抗体(ANA)、抗线粒体抗体(AMA)、抗平滑肌抗体(SMA)、抗肝肾微粒抗体(LKM)、抗可溶性肝抗原(SLA)等,用酶联免疫吸附试验(ELISA)定量测定抗线粒体M2亚型。结果 743例中诊断为AIH、PBC和重叠综合征分别为送检标本的5.11%、4.04%和1.75%,总计10.9%。AIH患者ANA阳性率为78.9%,AMA及M2亚型阳性率为18.4%,SMA阳性率为7.89%;PBC患者ANA阳性率为73.3%;AMA和M2阳性率为26.7%;重叠综合征患者ANA及AMA阳性率为100%。结论自身免疫性肝病抗体谱检测有助于自身免疫性肝病诊断,非病毒性肝炎诊断时应考虑自身免疫性肝病。 Objective To study the characteristics of autoantibodies spectrum of various autoimmune liver diseases in Chongqing area and its application value in clinic.Methods 81 cases diagnosed autoimmune liver diseases,from 743 tested samples of liver diseases,were collected and divided into 3 groups:autoimmune hepatitis group(AIH,38 cases),primary biliary cirrhosis group(PBC,30 cases) and overlap syndromes group(13 cases).First,ANA,AMA,SMA,LKM,SLA were tested by indirect immunofluorescence.Then,AMA and M2 were tested by ELISA.Results Among 743 cases,those diagnosed as AIH,PBC and overlap syndromes accounted for 5.11%,4.04% and 1.75% of the tested specimens respectively.In AIH patients,the positive rate was 78.9% in ANA,18.4% in AMA and M2 and 7.89% in ASMA;in PBC patients,the positive rate was 73.3% in ANA,26.7% in AMA and M2;in the patients with overlap syndromes,the positive rate was 100% in ANA and AMAConclusion The detection of antibodies spectrum of autoimmune 1iver diseases is helpful for diagnosis of autoimmune liver diseases and overlap syndromes;when diagnosing non viral hepatitis,autoimmune 1iver diseases should be considered.
出处 《检验医学与临床》 CAS 2010年第23期2602-2604,共3页 Laboratory Medicine and Clinic
关键词 自身免疫性肝炎 原发性胆汁性肝硬化 重叠综合征 自身抗体 autoimmune hepatitis primay biliary cirrhosis overlap syndromes antoantibody
  • 相关文献

参考文献9

  • 1McFarlane IG.Lesson about antibodies in autoimmtme hepatitis[J].Lancet,2000,355:1475-1476.
  • 2LaRusso NF,Shneider BL,Black D,et al.Primary scle-rosing cholangitis:summary of a workshop[J].Hepatology,2006,44(3):746-764.
  • 3Muratori P,Muratori L,Ferrari R,et al.Characterization and clinical impact of antinuclear antibodies inprimary biliary cirrhosis[J].J Gasteroenterol,2003,98(2):431-437.
  • 4McFarland IG.Lesson about antibodies in autoimmune hepatitis[J].Lancet,2000,35(5),1473-1475.
  • 5Homberg JC,Abuaf N,Bernard O,et al.Chronic active hepatitis associated with anti liver/kidney microsome type 1:a second type of"autoimmune"hepatitis[J].Hepatology,1987,25:1333-1339.
  • 6Hennes EM,Zeniya M,Czaja AJ,et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology,2008,48(1):169-176.
  • 7张利方,郑山根,阎有功,付丽萍.58例原发性胆汁性肝硬化患者自身抗体特征分析[J].中国免疫学杂志,2007,23(5):471-473. 被引量:9
  • 8姜小华,仲人前,方晓云,安峰,胡寅,孙建文,崔北年,万新亮,孔宪涛.原发性胆汁性肝硬化特异性AMAM_2抗体在5011名体检者中的筛查分析[J].中华检验医学杂志,2003,26(9):553-555. 被引量:30
  • 9Czaja AJ.Understanding the pathogenesis of autoimmune-hepatitis[J].Am J Gastroenterol,2001,96 (4):1224-1231.

二级参考文献13

  • 1金燕,郭婧婧.自身抗体在原发性胆汁性肝硬化中的应用分析[J].中国现代医学杂志,2005,15(1):76-77. 被引量:6
  • 2Metcalf JV, Mitchison HC,Palmer J, et al. Natural history of early primary biliary cirrbosis.Lancet ,1996,348:1399-1402.
  • 3Koizumi H, Onozuka Y, Shibata M, et al. Positive rate of antimitochondrial antibody in Japanese corporate workers .Rinsho Byori,2000,48:966-970.
  • 4Kisand KE, Metskula K, Kisand KV, et al. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples .J Gastroenterol,2001,36 :248-254.
  • 5Heathcote EJ. Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines.Hepatology ,2000, 31:1005-1013.
  • 6James OF, Bhoped R, Howel D, et al. Primary biliary cirrhosis once rare ,now commonin the United Kindom.Hepatology ,1999,30:390-394.
  • 7Leuschner U.primary biliary cirrhosis-presentation and diagnosis[J].Clin Liver Dis,2003; 7:741-758.
  • 8Heathcote E J.Management of primary biliary cirrhosis.The American association for the study of lire diseases practice guidelines[J].Hcpatology,2000; 31:1005-1013.
  • 9Miyakawa H,Tanaka A,Kikuchi K et al.Detection of antimitochondrial autoantibodies in immunofluurescent AMAM2 negative patients with primary biliary cirrhosis using recombinant autoantigcns[J].Hcpatology,2001; 34:243-248.
  • 10Long S A,Quan C,Van De Water J et al.lmmunoreactivity of organic mimeutupes of the En Component of pyruvate dehydrogenates connecting xenobiutics with primary biliary cirrhosis[J].lm munol,2001; 167:2956-2963.

共引文献36

同被引文献60

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部